0 CHECKOUT

PRODUCT FILTERS

REGION

1,214
582
579
524
524

COUNTRY

510
126
54
52
51

CATEGORIES

  • 314
  • 245
  • 234
  • 234
  • 211
  • 170
  • 161
  • 161
  • 140
  • 137
  • 135
  • 127
  • 80
  • 74
  • 42

PRICE

347
797
1,477
3,442

PUBLISHED

560
980
1,610
3,442

PRODUCT TYPE

2,630
358
287
136
26
2
1
1
1

Oncology Drugs

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

Corporate Reputation of Pharma in 2014 - a Perspective of Cancer Patient Groups - 2nd Edition

- Findings based on a survey of 197 patient groups with an interest in cancer from 37 countries - Survey conducted November 2014 to January 2015 This independent study, funded by the author, represents...

Published:  March 2015
Price:  From

Biomarker Technology Platforms for Cancer Diagnoses and Therapies 2014

Until superior therapeutic treatments are developed to prevent, treat and cure cancer, the best means of reducing mortality and morbidity in a disease this complex is early detection and diagnosis....

Published:  July 2014
Price:  From

Companion Diagnostics in Personalized Medicine and Cancer Therapy

Companion diagnostics (CDx) refers to a particular clinical diagnostic test that is under evaluation and is specifically linked to a known drug therapy. This linkage could be important in the therapeutic...

Published:  June 2014
Price:  From

Global Non Small Cell Lung Cancer Market & Pipeline Insight

Lung cancer has become one of the most prevalent cause of cancer related morbidity and mortality in past several decades across the world. Lungs are a pair of spongy tissues present in the thoracic...

Published:  January 2015
Price:  From

Global Non-small Cell Lung Cancer Market 2014-2018

About Non-small Cell Lung Cancer Non-small cell lung cancer occurs when normal cells grow and multiply without control after undergoing a cell transformation. Lung cancer is the leading cause of cancer...

Published:  September 2014
Price:  From

Global Multiple Myeloma Drugs Market 2015-2019

About Multiple Myeloma Multiple myeloma is a common cancer that affects the plasma cells, a type of white blood cell. It begins in the plasma cells of bone marrow. The primary function of the plasma...

Published:  December 2014
Price:  From

Cancer Nanomedicine Market & Pipeline Insight 2015

During the last decade, there has been significant impact of the emergence of nanotechnology on clinical therapeutics. The pharmaceutical industry has witnessed advances in biocompatible nanoscale drug...

Published:  February 2015
Price:  From

Non Hodgkin Lymphoma Therapeutics Market & Pipeline Insight

The market for Non Hodgkin Lymphoma has significant unmet medical necessities in terms of demand for innovative drugs and novel technologies. This is one of the major factors behind the market witnessing...

Published:  November 2014
Price:  From

Dendritic Cell and CAR-T Therapies, 2014 - 2024

The focus of drug developers is gradually moving towards immunotherapeutics, which make use of the body’s own immune system or its components to fight cancer. It is a relatively new concept, with the...

Published:  November 2014
Price:  From

Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018

About Non-Hodgkin Lymphoma (NHL) and its Diagnostic Procedures Non-Hodgkin lymphoma (NHL) is a condition of the human body leading to the production of abnormal lymphocytes. In normal circumstances,...

Published:  June 2014
Price:  From

Global Hodgkins Lymphoma Therapeutics Market 2014-2018

About Hodgkin's Lymphoma Hodgkin's Lymphoma (HL) is defined as the cancer of the lymph tissue, which is part of our immune system. The exact etiology of HL is unknown. However, the risk of developing...

Published:  August 2014
Price:  From

Small Molecule Cancer Drug Clinical Pipeline Insight 2015

Oncologists are continuously looking for better therapeutic options to effectively cure and prevent different types of malignancies. Conventionally, surgery and radiation were widely used for cancer...

Published:  January 2015
Price:  From

Global Oncology Biosimilars Market 2014-2018

About Oncology Biosimilars Biosimilars are follow-on versions of biological medicines that are developed after the expiry of the patent protection on the original product. Biosimilar medicines have...

Published:  November 2014
Price:  From

Global Skin Cancer Vaccine Market & Pipeline Insight 2015

Skin cancer incidences are increasing at alarming rates across the world causing high morbidity and mortality. Research and development in field is expected to change the present scenario by providing...

Published:  February 2015
Price:  From

Global Pancreatic Cancer Market 2014-2018

About Pancreatic Cancer Pancreatic cancer is a malignant cells form in the tissues of pancreas. Based on the initiation, pancreatic cancer can be classified into exocrine pancreatic cancer and endocrine...

Published:  October 2014
Price:  From

Global Cancer Monoclonal Antibodies Market & Pipeline Insight

Recent years have witnessed the emergence of monoclonal antibodies, which has the potential to offer less toxic and more efficient therapeutic alternatives for patients. Over the past decades, the researchers...

Published:  October 2014
Price:  From

Global Cancer Kinase Inhibitors Market & Pipeline Insight

The recent years have witnessed the emergence of kinase inhibitors, which have the potential to offer less toxic and more efficient therapeutic alternatives for patients. Over the past two decades,...

Published:  October 2014
Price:  From

Global Lung Cancer Vaccine Market & Pipeline Insight 2015

Lung cancer incidences are rapidly increasing and various therapeutics have been introduced in global market to provide better care to patients. Surgery and radiation therapy are not preferred for lung...

Published:  February 2015
Price:  From

Global Non-Melanoma Skin Cancer Market 2014-2018

About Non-melanoma Skin Cancer Non-melanoma skin cancer is one of the most common types of cancer in the world It develops in the upper layers of the skin, but not in melanocytes There are two types...

Published:  May 2014
Price:  From

Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024

Antibody drug conjugates (ADCs) are a new class of therapeutic agents, gaining increasing attention from both large and small pharmaceutical companies. Generally addressed as the marriage of an antibody...

Published:  August 2014
Price:  From
Loading Indicator

Our Clients